Knockdown of GNL3 inhibits LUAD cell growth by regulating Wnt–β-catenin pathway

Main Article Content

Guihong Dai
Yuejun Sun


apoptosis, GNL3, lung adenocarcinoma (LUAD), prognosis, Wnt/β-catenin


Background: Lung adenocarcinoma (LUAD) is a leading cause of tumor-associated mortality, and it is needed to find new target to combat this disease. Guanine nucleotide-binding -protein-like 3 (GNL3) mediates cell proliferation and apoptosis in several cancers, but its role in LUAD remains unclear.

Objective: To explore the expression and function of Guanine nucleotide-binding protein-like 3 (GNL3) in lung adenocarcinoma (LUAD) and its potential mechanism in inhibiting the growth of LUAD cells.

Methods: We evaluated the expression of GNL3 in LUAD tissues and its association with patient prognosis using databases and immunohistochemistry. Cell proliferation was assessed by CCK-8 assay as well as colony formation, while apoptosis was evaluated by FCM. The effect of GNL3 knockdown on the Wnt/β-catenin axis was investigated by Immunoblot analysis.

Results: GNL3 is overexpressed in LUAD tissues and is correlated with poor prognosis. Knockdown of GNL3 significantly inhibited the growth as well as induced apoptosis in A549 as well as H1299 cells. Furthermore, we found that the inhibitory effect of GNL3 knockdown on LUAD cell growth is associated with the downregulation of the Wnt/β-catenin axis.

Conclusion: GNL3 is key in the progression of LUAD by metiating Wnt/β-catenin axis. Targeting GNL3 may represent a novel therapeutic method for LUAD treatment.

Abstract 99 | PDF Downloads 126 HTML Downloads 0 XML Downloads 3


1. Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117. 10.1038/s41419-017-0063-y

2. Jones DR, Wu YL, Tsuboi M, Herbst RS. Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons. J Thorac Cardiovasc Surg. 2021;162(1):288–92. 10.1016/j.jtcvs.2021.02.008

3. Glanville AR, Wilson BE. Lung transplantation for non-small cell lung cancer and multifocal bronchioalveolar cell carcinoma. Lancet Oncol. 2018;19(7):e351–8. 10.1016/S1470-2045(18)30297-3

4. Muto S, Enta A, Maruya Y, Inomata S, Yamaguchi H, Mine H, et al. Wnt/beta-catenin signaling and resistance to immune checkpoint inhibitors: From non-small-cell lung cancer to other cancers. Biomedicines. 2023;11(1):190. 10.3390/biomedicines11010190

5. Li Y, Liu C, Zhang X, Huang X, Liang S, Xing F, et al. CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/beta-catenin signalling pathway. Br J Cancer. 2022;126(12):1684–94. 10.1038/s41416-022-01747-0

6. Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/beta-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. 10.1038/s41392-021-00762-6

7. Katoh M, Katoh M. WNT signaling and cancer stemness. Essays Biochem. 2022;66(4):319–31. 10.1042/EBC20220016

8. Liu P, Guo W, Su Y, Chen C, Ma Y, Ma P, et al. Multi-omics analysis of GNL3L expression, prognosis, and immune value in pan-cancer. Cancers (Basel). 2022;14(19):4595. 10.3390/cancers14194595

9. Babak MV, Meier SM, Huber KVM, Reynisson J, Legin AA, Jakupec MA, et al. Target profiling of an antimetastatic RAPTA agent by chemical proteomics: Relevance to the mode of action. Chem Sci. 2015;6(4):2449–56. 10.1039/C4SC03905J

10. Zhang S, Zhao H, Chen Y, Zhang Y. GNL3 regulates SIRT1 transcription and promotes hepatocellular carcinoma stem cell-like features and metastasis. J Oncol. 2022;2022:1555670. 10.1155/2022/1555670

11. Dai R, Wu M, Zhang Y, Zhu Z, Shi J. G protein nucleolar 3 promotes non-Hodgkin lymphoma progression by activating the Wnt/beta-catenin signaling pathway. Exp Cell Res. 2021;409(2):112911. 10.1016/j.yexcr.2021.112911

12. Tang X, Zha L, Li H, Liao G, Huang Z, Peng X, et al. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway. Oncol Rep. 2017;38(4):2023–32. 10.3892/or.2017.5923

13. Wei X, Li X, Hu S, Cheng J, Cai R. Regulation of ferroptosis in lung adenocarcinoma. Int J Mol Sci. 2023;24(19):14614. 10.3390/ijms241914614

14. Kumar S, Shuaib M, Al Asmari AF, Alqahtani F, Gupta S. GNL3 and PA2G4 as prognostic biomarkers in prostate cancer. Cancers (Basel). 2023;15(10):2723. 10.3390/cancers15102723

15. Chen J, Dong S, Hu J, Duan B, Yao J, Zhang R, et al. Guanine nucleotide binding protein-like 3 is a potential prognosis indicator of gastric cancer. Int J Clin Exp Pathol. 2015;8(10):13273–8.

16. Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, et al. HIF-1a-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/beta-catenin and Notch signaling. Theranostics. 2020;10(6):2553–70. 10.7150/thno.41120

17. Wu XT, Wang YH, Cai XY, Dong Y, Cui Q, Zhou YN, et al. RNF115 promotes lung adenocarcinoma through Wnt/beta-catenin pathway activation by mediating APC ubiquitination. Cancer Metab. 2021;9(1):7. 10.1186/s40170-021-00243-y

18. Wang Z, Fang Z, Chen G, Liu B, Xu J, Li F, et al. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma through the Wnt/beta-catenin pathway. Neoplasia. 2021;23(2):222–33. 10.1016/j.neo.2020.12.005